ReviewWorld journal of methodology2026
Comparison of older and newer sedation agents in bronchoscopy.
Review in World journal of methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Flexible bronchoscopy is an important diagnostic and therapeutic modality in pulmonary medicine. Appropriate sedation is essential for patient safety and comfort. Several agents, such as benzodiazepine and opiates (fentanyl, Midazolam, and morphine), have been used for conscious sedation and anxiolytics. Lately, there has been an influx of newer sedation agents that have been valuable in bronchoscopy because of their beneficial properties. For example, Ketamine, a dissociative anesthetic, has been used during bronchoscopic procedures as an alternative to conventional sedatives or as an adjunct to them. Its bronchodilatory effects, minimal respiratory depression, sympathomimetic effect leading to hemodynamic stability, and analgesic properties make it particularly valuable in high-risk populations, including patients with respiratory compromise. Besides Ketamine, Esketamine, Dexmedetomidine, and other agents are also being used. This minireview explores the role of older and newer agents in bronchoscopy, highlighting their efficacy, safety profile, and potential advantages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.